Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase II
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for…
Approval
Blueprint Medicines Announces European Medicines Agency Validation of Marketing Authorization Application…
Phase I
Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial…
Phase II
InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi…
Deals
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part…
Commercial
Novartis Close to Settling Kickback Lawsuit
Deals
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data…
Home
Authors
Posts by Biospace News
Biospace News
1622 POSTS
0 COMMENTS
Others
Takeda Eyes Additional Divestitures to Pare Down Shire Deal Debt
Biospace News
-
July 18, 2019
0
Commercial
Novartis Close to Settling Kickback Lawsuit
Biospace News
-
July 18, 2019
0
Deals
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part...
Biospace News
-
July 18, 2019
0
Deals
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi...
Biospace News
-
July 18, 2019
0
Others
Hansa Biopharma Interim Report January-June 2019
Biospace News
-
July 18, 2019
0
1
2
3
...
325
Page 1 of 325
- Advertisement -
MOST POPULAR
J&J Takes $900 Million Loss as It Writes off RSV Drug...
March 22, 2019
Europe’s Peroxfarma Brings its Expertise in Joint Care to America
February 12, 2019
Nemus Bioscience Signs Agreement with Pharmaceuticals International Inc. to Develop Dosage...
February 14, 2019
AbCellera Announces Multi-Target Partnership Agreement with a Top 5 Global Pharma
February 14, 2019
Load more
HOT NEWS
Commercial
MEI Pharma Reports Second Quarter Fiscal Year 2019 Results and Operational...
Others
Scottish Medicines Consortium July 2019 decisions
Commercial
Reckitt Benckiser to pay $1.4 billion to settle US probes into...
Commercial
Actinium Highlights Actimab-A and Venetoclax Synergies Observed in New Studies Presented...
